Radu Moldovan
Research Subjects
Radu Moldovan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Vlad Andrei Ichim
Iuliu Haţieganu" University of Medicine and Pharmacy, Department of Internal Medicine, Street Victor Babeș 8, Cluj-Napoca, Cluj, 400347, Romania
2 shared publications Baia Mare “Dr. Constantin Opris” Emergency County Hospital
1 shared publication- Diane Gumina
University of Colorado School of Medicine 1 Division of Reproductive Sciences, Department of Obstetrics and Gynecology Aurora, CO 80045 , USA
1 shared publication - Emily J. Su
Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO 80045, USA
1 shared publication Gabriel Aurelian Pufu
1 shared publication- Kathryn McPeak
University of Colorado School of Medicine 1 Division of Reproductive Sciences, Department of Obstetrics and Gynecology Aurora, CO 80045 , USA
1 shared publication
Latest Publications
- 28 December 2024
- Published by Elsevier in Legal Medicine
- Vol. 72, 102565
Immunohistochemical study of ATP1A3 and plakophilin 2 as new potential markers in the diagnosis of myocardial ischemia
- 28 December 2024
- Published by Elsevier in Legal Medicine
- Vol. 72, 102565
Immunohistochemical study of ATP1A3 and plakophilin 2 as new potential markers in the diagnosis of myocardial ischemia
- 30 September 2024
- Published by AMALTEA Medical Publishing House in Romanian Medical Journal
- Vol. 71 (3) , 201-209
Comprehensive statistical analysis of causes of death and histopathological diagnosis in medico-legal investigations of sudden cardiac deaths
Background and objectives. Sudden cardiac deaths (SCDs) have a significant impact worldwide. Its distribution trends may vary across different communities globally. Consequently, investigating sudden cardiac deaths necessitates a regional, multi-faceted approach. This study aims to ascertain the pathological background of the patients who died in the context of sudden cardiac death and analyze it statistically to generate some trends and define the occurrence of disease. Materials and methods. We conducted a retrospective analysis of the causes of death for cases from the Legal-Medicine Department of Maramures County, Romania, between 2021 and 2023. From this cohort, we identified and selected cases of SCD and conducted a statistical analysis of the number of cases, gender distribution, age group distribution, and the underlying cardiac pathology that led to this outcome. Results. 276 sudden cardiac deaths (SCD) were identified from 1,186 autopsies. Males accounted for 75% of SCD cases, with a mean age of 58.8 years. Advanced myocardial fibrosis (41.6%) was the most frequent cause, followed by coronary artery disease (18.12%) and acute myocardial infarction (17.4%). Males had significantly more AMI cases (p = 0.045), while females had more coronary artery disease and advanced myocardial fibrosis, though not statistically significant. Conclusions. Sudden cardiac death predominantly affects males, particularly those aged 51–60, with advanced myocardial fibrosis being the most common cause. The gender difference in AMI prevalence was significant, highlighting the need for targeted prevention and diagnostic improvements. Further research in liaison with experts in all fields is required.
- 30 September 2024
- Published by AMALTEA Medical Publishing House in Romanian Medical Journal
- Vol. 71 (3) , 201-209
Comprehensive statistical analysis of causes of death and histopathological diagnosis in medico-legal investigations of sudden cardiac deaths
Background and objectives. Sudden cardiac deaths (SCDs) have a significant impact worldwide. Its distribution trends may vary across different communities globally. Consequently, investigating sudden cardiac deaths necessitates a regional, multi-faceted approach. This study aims to ascertain the pathological background of the patients who died in the context of sudden cardiac death and analyze it statistically to generate some trends and define the occurrence of disease. Materials and methods. We conducted a retrospective analysis of the causes of death for cases from the Legal-Medicine Department of Maramures County, Romania, between 2021 and 2023. From this cohort, we identified and selected cases of SCD and conducted a statistical analysis of the number of cases, gender distribution, age group distribution, and the underlying cardiac pathology that led to this outcome. Results. 276 sudden cardiac deaths (SCD) were identified from 1,186 autopsies. Males accounted for 75% of SCD cases, with a mean age of 58.8 years. Advanced myocardial fibrosis (41.6%) was the most frequent cause, followed by coronary artery disease (18.12%) and acute myocardial infarction (17.4%). Males had significantly more AMI cases (p = 0.045), while females had more coronary artery disease and advanced myocardial fibrosis, though not statistically significant. Conclusions. Sudden cardiac death predominantly affects males, particularly those aged 51–60, with advanced myocardial fibrosis being the most common cause. The gender difference in AMI prevalence was significant, highlighting the need for targeted prevention and diagnostic improvements. Further research in liaison with experts in all fields is required.
- 25 June 2023
- Published by Elsevier in Legal Medicine
- Vol. 64, 102293
Recent perspectives on the early expression immunohistochemical markers in post-mortem recognition of myocardial infarction
- 25 June 2023
- Published by Elsevier in Legal Medicine
- Vol. 64, 102293
Recent perspectives on the early expression immunohistochemical markers in post-mortem recognition of myocardial infarction
- Open Access
- 11 May 2021
- Published by Portland Press Ltd. in Clinical Science
- Vol. 135 (9) , 1127-1143
Human placental villous stromal extracellular matrix regulates fetoplacental angiogenesis in severe fetal growth restriction
Pregnancies complicated by severe, early-onset fetal growth restriction with abnormal Doppler velocimetry (FGRadv) have a sparse villous vascular tree secondary to impaired angiogenesis. As endothelial cell (EC) and stromal matrix interactions are key regulators of angiogenesis, we investigated the role of placental stromal villous matrix on fetoplacental EC angiogenesis. We have developed a novel model of generating placental fibroblast (FB) cell-derived matrices (CDMs), allowing us to interrogate placenta-specific human EC and stromal matrix interactions and their effects on fetoplacental angiogenesis. We found that as compared with control ECs plated on control matrix, FGRadv ECs plated on FGRadv matrix exhibited severe migrational defects, as measured by velocity, directionality, accumulated distance, and Euclidean distance in conjunction with less proliferation. However, control ECs, when interacting with FGRadv CDM, also demonstrated significant impairment in proliferation and migratory properties. Conversely several angiogenic attributes were rescued in FGRadv ECs subjected to control matrix, demonstrating the importance of placental villous stromal matrix and EC-stromal matrix interactions in regulation of fetoplacental angiogenesis.
- 11 May 2021
- Published by Portland Press Ltd. in Clinical Science
- Vol. 135 (9) , 1127-1143
Open AccessHuman placental villous stromal extracellular matrix regulates fetoplacental angiogenesis in severe fetal growth restriction
Pregnancies complicated by severe, early-onset fetal growth restriction with abnormal Doppler velocimetry (FGRadv) have a sparse villous vascular tree secondary to impaired angiogenesis. As endothelial cell (EC) and stromal matrix interactions are key regulators of angiogenesis, we investigated the role of placental stromal villous matrix on fetoplacental EC angiogenesis. We have developed a novel model of generating placental fibroblast (FB) cell-derived matrices (CDMs), allowing us to interrogate placenta-specific human EC and stromal matrix interactions and their effects on fetoplacental angiogenesis. We found that as compared with control ECs plated on control matrix, FGRadv ECs plated on FGRadv matrix exhibited severe migrational defects, as measured by velocity, directionality, accumulated distance, and Euclidean distance in conjunction with less proliferation. However, control ECs, when interacting with FGRadv CDM, also demonstrated significant impairment in proliferation and migratory properties. Conversely several angiogenic attributes were rescued in FGRadv ECs subjected to control matrix, demonstrating the importance of placental villous stromal matrix and EC-stromal matrix interactions in regulation of fetoplacental angiogenesis.